Status:
UNKNOWN
SATURN 04 Nosocomial Acquisition Study
Lead Sponsor:
Catholic University of the Sacred Heart
Collaborating Sponsors:
Clinical Centre of Serbia
National Institute of Infectious Diseases Matei Bals
Conditions:
Bacterial Resistance
Infection Resistant to Multiple Drugs
Eligibility:
All Genders
18+ years
Brief Summary
The study is the WP4 of the EU-funded (7th FW) project SATURN (Impact of Specific Antibiotic Therapies on the prevalence of hUman host ResistaNt bacteria). A total of 6 surgical and 6 medical wards wi...
Detailed Description
Nasal samples for the detection of MRSA and rectal samples (stoma sample in case of colostomy) for ESBL producing gram negative bacteria will be obtained at hospital admission and discharge. Patients ...
Eligibility Criteria
Inclusion
- All hospitalized non ICU patients at hospital admission/discharge;
- Age \>18 years old;
- All patients starting intravenous and/or oral antibiotic treatments during hospitalization.
Exclusion
- Pregnancy;
- Recent nose surgery (for nasal swabs).
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2015
Estimated Enrollment :
16680 Patients enrolled
Trial Details
Trial ID
NCT01208519
Start Date
November 1 2010
End Date
January 1 2015
Last Update
February 13 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Università Cattolica del Sacro Cuore; Policlinico A. Gemelli
Rome, Lazio, Italy, 00100
2
Institute of Infectious Diseases Matei Bals
Bucharest, Romania, 021105
3
Clinical Center of Serbia
Belgrade, Serbia, 11000